Mehmet Sait Coşkun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mehmet Sait Coşkun has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Raif Kılıç
Department of Cardiology Mardin Artuklu University Faculty of Medicine Mardin Turkey
4 shared publications - Tuncay Güzel
Department of Cardiology, University of Health Sciences, Gazi Yaşargil Training and Research Hospital, Diyarbakır 21070, Türkiye
4 shared publications - Adem Aktan
Department of Cardiology, Mardin Artuklu University, Mardin, Turkey
3 shared publications - Muhammed Raşit Tanırcan
Mardin Eğitim ve Araştırma Hastanesi
3 shared publications - Serdar Söner
Department of Cardiology, Gazi Yaşargil Training and Research Hospital, University of Health Sciences, Diyarbakır, Türkiye
3 shared publications - Abdulkadir Arpa
Department of Cardiology, Bismil State Hospital, Diyarbakır, Türkiye
2 shared publications
Latest Publications
- 26 October 2026
- Published by Dokuz Eylul Universitesi Tip Fakultesi Dergisi in Developments and Experiments in Health and Medicine
- Vol. 40 (4) , 481-489
Systemic Inflammatory–Nutritional Status and Coronary Collateral Development in Chronic Total Occlusion: The Role of the CALLY Index
Background:In patients with chronic total occlusion, collateral development varies despite similar angiographic disease burden. The C-reactive protein–albumin–lymphocyte (CALLY) index may reflect systemic inflammatory, nutritional, and immune status, but its association with collateral development in chronic total occlusion (CTO) is not well defined.Methods:We retrospectively evaluated 306 consecutive patients diagnosed with CTO on coronary angiography at a single center between January 2023 and December 2025. Angiographic collateralization was stratified via the Rentrop criteria, where categories 0–1 represented suboptimal vascular recruitment, whereas classes 2–3 denoted a well-developed collateral network. Baseline clinical features, laboratory measurements, and angiographic findings were analyzed according to collateral status. Logistic regression models were used to test the independent relationship between the CALLY index and good collateral development, while ROC analysis assessed its discriminatory performance.Results:Patients with poor collateral development showed a more pronounced inflammatory profile, accompanied by lower albumin levels, lymphocyte counts, and CALLY index values. The median CALLY index was lower among patients with poor collateralization than among those with good collateralization [2.70 (1.30–7.33) vs. 4.56 (2.42–9.27), p
- 26 October 2026
- Published by Dokuz Eylul Universitesi Tip Fakultesi Dergisi in Developments and Experiments in Health and Medicine
- Vol. 40 (4) , 481-489
Systemic Inflammatory–Nutritional Status and Coronary Collateral Development in Chronic Total Occlusion: The Role of the CALLY Index
Background:In patients with chronic total occlusion, collateral development varies despite similar angiographic disease burden. The C-reactive protein–albumin–lymphocyte (CALLY) index may reflect systemic inflammatory, nutritional, and immune status, but its association with collateral development in chronic total occlusion (CTO) is not well defined.Methods:We retrospectively evaluated 306 consecutive patients diagnosed with CTO on coronary angiography at a single center between January 2023 and December 2025. Angiographic collateralization was stratified via the Rentrop criteria, where categories 0–1 represented suboptimal vascular recruitment, whereas classes 2–3 denoted a well-developed collateral network. Baseline clinical features, laboratory measurements, and angiographic findings were analyzed according to collateral status. Logistic regression models were used to test the independent relationship between the CALLY index and good collateral development, while ROC analysis assessed its discriminatory performance.Results:Patients with poor collateral development showed a more pronounced inflammatory profile, accompanied by lower albumin levels, lymphocyte counts, and CALLY index values. The median CALLY index was lower among patients with poor collateralization than among those with good collateralization [2.70 (1.30–7.33) vs. 4.56 (2.42–9.27), p
- Open Access
- 13 July 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Comparative prognostic value of GNRI, PNI, and CONUT scores for long-term mortality in patients undergoing transcatheter aortic valve replacement
This study aimed to comparatively evaluate the association between geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and control
- 13 July 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Open AccessComparative prognostic value of GNRI, PNI, and CONUT scores for long-term mortality in patients undergoing transcatheter aortic valve replacement
This study aimed to comparatively evaluate the association between geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and control
- 1 June 2026
- Published by Wiley in Echocardiography
- Vol. 43 (6) , e70521
Impact of Reverse Dipper and Non‐Dipper Blood Pressure Patterns on Myocardial Performance Index in Hypertensive Patients
Background: Abnormal nocturnal blood pressure patterns are associated with subclinical cardiac dysfunction in hypertension (HT). However, their relationship with the myocardial performance index (MPI) is not well‐defined. Methods: This retrospective study included 196 hypertensive patients who underwent 24‐h ambulatory blood pressure monitoring (ABPM). Patients were classified as dipper, non‐dipper, and reverse dipper according to nocturnal systolic blood pressure variation. Echocardiographic parameters, including MPI, were compared. Multivariate linear regression analysis was performed. Results: The highest MPI values were found in the reverse dipper group ( p < 0.001). Reverse dipper ( B = 0.054, p < 0.001) and non‐dipper ( B = 0.023, p = 0.002) patterns were independently associated with increased MPI. MPI showed moderate discriminatory power in predicting the reverse dipper pattern (area under the curve [AUC] = 0.693). Conclusion: Reverse dipper and non‐dipper patterns are associated with increased MPI. This finding suggests an association between abnormal circadian blood pressure patterns and subclinical cardiac dysfunction. Further prospective studies are required to determine clinical relevance.
- 1 June 2026
- Published by Wiley in Echocardiography
- Vol. 43 (6) , e70521
Impact of Reverse Dipper and Non‐Dipper Blood Pressure Patterns on Myocardial Performance Index in Hypertensive Patients
Background: Abnormal nocturnal blood pressure patterns are associated with subclinical cardiac dysfunction in hypertension (HT). However, their relationship with the myocardial performance index (MPI) is not well‐defined. Methods: This retrospective study included 196 hypertensive patients who underwent 24‐h ambulatory blood pressure monitoring (ABPM). Patients were classified as dipper, non‐dipper, and reverse dipper according to nocturnal systolic blood pressure variation. Echocardiographic parameters, including MPI, were compared. Multivariate linear regression analysis was performed. Results: The highest MPI values were found in the reverse dipper group ( p < 0.001). Reverse dipper ( B = 0.054, p < 0.001) and non‐dipper ( B = 0.023, p = 0.002) patterns were independently associated with increased MPI. MPI showed moderate discriminatory power in predicting the reverse dipper pattern (area under the curve [AUC] = 0.693). Conclusion: Reverse dipper and non‐dipper patterns are associated with increased MPI. This finding suggests an association between abnormal circadian blood pressure patterns and subclinical cardiac dysfunction. Further prospective studies are required to determine clinical relevance.
- 22 October 2025
- Published by Galenos Yayinevi in Cardiovascular Surgery and Interventions
- Vol. 12 (3) , 179-187
How optimal is the treatment for heart failure patients with low ejection fraction?
Objectives: The aim of our study was to investigate the medical treatment and doses used in patients with a diagnosis of heart failure (HF) and whether these vital drugs were used by cardiologists at the required doses in patients with indications. Patients and methods: This single-center, prospective study included a total of 419 chronic HF (CHF) patients (275 males, 144 females; mean age: 65.2±13.8 years; range, 22 to 94 years) between April 1st, 2020 and November 15th, 2020. Patients and their relatives were interviewed and sociodemographic data of the patients were recorded. Routine hematological and biochemical parameters, electrocardiographic findings, electrocardiographic and echocardiographic findings, and systolic and diastolic pressure data were recorded during follow-up. The New York Heart Association (NYHA) functional classes were also determined. Results: The causes of CHF were as follows: 55.6% ischemic heart disease, 33.9% dilated cardiomyopathy (CMP), 3.8% valvular, 1.9% peripartum CMP, 1.9% post-chemotherapy (CT), 1% non-compaction CMP, and 1.9% other causes. The most common reason for not receiving medical treatment at the maximal doses recommended by the guidelines was "not recommended by the physician" (beta-blockers 49.6%, n=208, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers [ACEI/ARBs] 44.6%, n=187, mineralocorticoid receptor antagonists [MRAs] 38.7%, n=162). The second most common reason was the lack of desired follow-ups due to socioeconomic reasons. Conclusion: The most common reason why HF patients do not receive optimal treatment, including beta-blocker, ACEI/ARB, and MRA groups is that clinicians do not recommend it. This study may be a reference to the fact that clinicians' maximal sensitivity in treatment optimization in fragile patient groups, such as HF, would significantly change patient outcomes.
- 22 October 2025
- Published by Galenos Yayinevi in Cardiovascular Surgery and Interventions
- Vol. 12 (3) , 179-187
How optimal is the treatment for heart failure patients with low ejection fraction?
Objectives: The aim of our study was to investigate the medical treatment and doses used in patients with a diagnosis of heart failure (HF) and whether these vital drugs were used by cardiologists at the required doses in patients with indications. Patients and methods: This single-center, prospective study included a total of 419 chronic HF (CHF) patients (275 males, 144 females; mean age: 65.2±13.8 years; range, 22 to 94 years) between April 1st, 2020 and November 15th, 2020. Patients and their relatives were interviewed and sociodemographic data of the patients were recorded. Routine hematological and biochemical parameters, electrocardiographic findings, electrocardiographic and echocardiographic findings, and systolic and diastolic pressure data were recorded during follow-up. The New York Heart Association (NYHA) functional classes were also determined. Results: The causes of CHF were as follows: 55.6% ischemic heart disease, 33.9% dilated cardiomyopathy (CMP), 3.8% valvular, 1.9% peripartum CMP, 1.9% post-chemotherapy (CT), 1% non-compaction CMP, and 1.9% other causes. The most common reason for not receiving medical treatment at the maximal doses recommended by the guidelines was "not recommended by the physician" (beta-blockers 49.6%, n=208, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers [ACEI/ARBs] 44.6%, n=187, mineralocorticoid receptor antagonists [MRAs] 38.7%, n=162). The second most common reason was the lack of desired follow-ups due to socioeconomic reasons. Conclusion: The most common reason why HF patients do not receive optimal treatment, including beta-blocker, ACEI/ARB, and MRA groups is that clinicians do not recommend it. This study may be a reference to the fact that clinicians' maximal sensitivity in treatment optimization in fragile patient groups, such as HF, would significantly change patient outcomes.
- Open Access
- 20 January 2025
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 25 (1) , 1-11
Association between the triglyceride-glucose index and contrast-induced nephropathy in chronic total occlusion patients undergoing percutaneous coronary intervention
The triglyceride glucose (TyG) index is a biomarker of insulin resistance and is associated with an increased risk of cardiovascular events. Contrast-induced nephropathy (CIN) is an important complication that causes poor outcomes in patients undergoing percutaneous coronary intervention (PCI). In this study, we aimed to investigate the relationship between the TyG index and CIN and mortality in patients who underwent PCI due to chronic total coronary occlusion (CTO). Two hundred eighteen individuals from three separate medical centers who underwent procedural PCI between February 2010 and April 2012 and had a CTO lesion in at least one coronary artery were recruited. According to the TyG index, patients were divided into two groups. Patients with a TyG index ≥ 8.65 were included in Group 1, and patients with a TyG index < 8.65 were included in Group 2. Patients were followed up for 96 months. The main outcome was the development of CIN and mortality. The mean age of the patients (65.8 ± 10.94 vs. 61.68 ± 11.4, P = 0.009), diabetes mellitus (60 [44.8%] vs. 11 [13.1%], P < 0.001), and dyslipidemia rates (52 [38.8%] vs. 21 [25%], P = 0.036) were higher in group 1. In multivariable logistic regression analysis, it was seen that age (OR = 1.04, 95% CI = 1.01–1.08, P = 0.020), chronic kidney disease (OR = 2.34, 95% CI = 1.02–5.33, P = 0.044), peripheral artery disease (OR = 5.66, 95% CI = 1.24–25.91, p = 0.026), LVEF (OR = 0.95, 95% CI = 0.92–0.99, P = 0.005), LDL cholesterol levels (OR = 1.00, 95%CI = 1.00–1.02, P = 0.024) and TyG index (OR = 2.17, 95% CI = 1.21–3.89, P = 0.009) were independent predictors of the development of CIN. Our study demonstrates a correlation between the TyG index and the prevalence of CIN in patients with CTO undergoing PCI. Adding the TyG index to the routine clinical evaluation of patients with CTO undergoing PCI may help protect patients from the development of CIN.
- 20 January 2025
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 25 (1) , 1-11
Open AccessAssociation between the triglyceride-glucose index and contrast-induced nephropathy in chronic total occlusion patients undergoing percutaneous coronary intervention
The triglyceride glucose (TyG) index is a biomarker of insulin resistance and is associated with an increased risk of cardiovascular events. Contrast-induced nephropathy (CIN) is an important complication that causes poor outcomes in patients undergoing percutaneous coronary intervention (PCI). In this study, we aimed to investigate the relationship between the TyG index and CIN and mortality in patients who underwent PCI due to chronic total coronary occlusion (CTO). Two hundred eighteen individuals from three separate medical centers who underwent procedural PCI between February 2010 and April 2012 and had a CTO lesion in at least one coronary artery were recruited. According to the TyG index, patients were divided into two groups. Patients with a TyG index ≥ 8.65 were included in Group 1, and patients with a TyG index < 8.65 were included in Group 2. Patients were followed up for 96 months. The main outcome was the development of CIN and mortality. The mean age of the patients (65.8 ± 10.94 vs. 61.68 ± 11.4, P = 0.009), diabetes mellitus (60 [44.8%] vs. 11 [13.1%], P < 0.001), and dyslipidemia rates (52 [38.8%] vs. 21 [25%], P = 0.036) were higher in group 1. In multivariable logistic regression analysis, it was seen that age (OR = 1.04, 95% CI = 1.01–1.08, P = 0.020), chronic kidney disease (OR = 2.34, 95% CI = 1.02–5.33, P = 0.044), peripheral artery disease (OR = 5.66, 95% CI = 1.24–25.91, p = 0.026), LVEF (OR = 0.95, 95% CI = 0.92–0.99, P = 0.005), LDL cholesterol levels (OR = 1.00, 95%CI = 1.00–1.02, P = 0.024) and TyG index (OR = 2.17, 95% CI = 1.21–3.89, P = 0.009) were independent predictors of the development of CIN. Our study demonstrates a correlation between the TyG index and the prevalence of CIN in patients with CTO undergoing PCI. Adding the TyG index to the routine clinical evaluation of patients with CTO undergoing PCI may help protect patients from the development of CIN.
- 11 September 2024
- Published by Academician Publishing
- p. 51-56
Pulmoner Darlıkta Girişimsel Tedavi
Pulmoner stenoz, sağ ventrikül çıkış yolunda pulmoner kapak, kapak anülüsü veya pulmoner arterleri içerebilen bir obstrüksiyonla karakterize edilen doğuştan kalp anomalisi olarak tanımlanır. Vakaların %7 ila %12'sinde izole olarak görülmesine rağmen, %25 ila %30'unda Fallot tetralojisi gibi diğer konjenital kalp defektleri ile daha sık ilişkilidir. Obstrüksiyonun derecesine ve kalbin telafi kapasitesine bağlı olarak, orta ila şiddetli stenozu olan bireylerde eforla ortaya çıkan dispne ve yorgunluk gibi semptomatik belirtiler genellikle gözlenir. Tanı öncelikle ekokardiyografi ile konulur, ancak girişimsel prosedürler için değerlendirilen hastalarda kardiyak bilgisayarlı tomografi (CCT) ve kardiyak manyetik rezonans görüntüleme (CMR) sıkça kullanılmaktadır. Tedavi yaklaşımı, obstrüksiyonun şiddeti ve kapak anatomik özelliklerine göre değişiklik gösterir. Balon pulmoner valvüloplasti (BPV), ciddi kapak stenozu vakalarında açık kalp cerrahisi gereksinimini önemli ölçüde azaltmış olsa da, perkütan tekniklerin uygun olmadığı durumlarda cerrahi müdahale hala gerekli olmaktadır. Pulmonary stenosis is a congenital cardiac anomaly characterized by obstruction within the right ventricular outflow tract, which may involve the pulmonary valve, annulus, or the pulmonary arteries. Although it occurs in isolation in 7% to 12% of cases, it is more frequently associated with other congenital heart defects, such as tetralogy of Fallot, in 25% to 30% of patients. Symptomatic manifestations, including exertional dyspnea and fatigue, are generally observed in individuals with moderate to severe stenosis, contingent on the extent of obstruction and the compensatory capacity of the heart. Diagnosis is primarily achieved through echocardiography, with cardiac computed tomography (CCT) and cardiac magnetic resonance imaging (CMR) frequently employed in patients being evaluated for interventional procedures. The therapeutic approach varies according to the severity of the obstruction and the anatomical characteristics of the valve. While balloon pulmonary valvuloplasty (BPV) has significantly reduced the necessity for open-heart surgery in cases of severe valvular stenosis, surgical intervention remains indicated when percutaneous techniques are not feasible.
- 11 September 2024
- Published by Academician Publishing
- p. 51-56
Pulmoner Darlıkta Girişimsel Tedavi
Pulmoner stenoz, sağ ventrikül çıkış yolunda pulmoner kapak, kapak anülüsü veya pulmoner arterleri içerebilen bir obstrüksiyonla karakterize edilen doğuştan kalp anomalisi olarak tanımlanır. Vakaların %7 ila %12'sinde izole olarak görülmesine rağmen, %25 ila %30'unda Fallot tetralojisi gibi diğer konjenital kalp defektleri ile daha sık ilişkilidir. Obstrüksiyonun derecesine ve kalbin telafi kapasitesine bağlı olarak, orta ila şiddetli stenozu olan bireylerde eforla ortaya çıkan dispne ve yorgunluk gibi semptomatik belirtiler genellikle gözlenir. Tanı öncelikle ekokardiyografi ile konulur, ancak girişimsel prosedürler için değerlendirilen hastalarda kardiyak bilgisayarlı tomografi (CCT) ve kardiyak manyetik rezonans görüntüleme (CMR) sıkça kullanılmaktadır. Tedavi yaklaşımı, obstrüksiyonun şiddeti ve kapak anatomik özelliklerine göre değişiklik gösterir. Balon pulmoner valvüloplasti (BPV), ciddi kapak stenozu vakalarında açık kalp cerrahisi gereksinimini önemli ölçüde azaltmış olsa da, perkütan tekniklerin uygun olmadığı durumlarda cerrahi müdahale hala gerekli olmaktadır. Pulmonary stenosis is a congenital cardiac anomaly characterized by obstruction within the right ventricular outflow tract, which may involve the pulmonary valve, annulus, or the pulmonary arteries. Although it occurs in isolation in 7% to 12% of cases, it is more frequently associated with other congenital heart defects, such as tetralogy of Fallot, in 25% to 30% of patients. Symptomatic manifestations, including exertional dyspnea and fatigue, are generally observed in individuals with moderate to severe stenosis, contingent on the extent of obstruction and the compensatory capacity of the heart. Diagnosis is primarily achieved through echocardiography, with cardiac computed tomography (CCT) and cardiac magnetic resonance imaging (CMR) frequently employed in patients being evaluated for interventional procedures. The therapeutic approach varies according to the severity of the obstruction and the anatomical characteristics of the valve. While balloon pulmonary valvuloplasty (BPV) has significantly reduced the necessity for open-heart surgery in cases of severe valvular stenosis, surgical intervention remains indicated when percutaneous techniques are not feasible.
- 11 September 2024
- Published by Academician Publishing
Erişkin Konjenital Kalp Hastalıklarına Perkütan Girişimsel Yaklaşımlar
İnsan bilişsel, duyuşsal ve fiziksel olarak doğaya karşı yüksek bir adaptasyon yetisi ile dünyaya gelir. Bu yeti bireysel farklılıklar gösterse de tüm insanlarda zamanla belirginleşerek farklı şekillerde öğrenme ve yapabilme yeteneği olarak kendini gösterir. Fakat genetik ve yaşamsal faktörlerin etkisiyle bazı insanların farklı alanlarda öğrenme ve yapabilme potansiyelleri akranlarına göre çok daha yüksektir. Yetenekli sıfatı da bu yüksek potansiyelli insanları tamınlamak için kullanılır.
- 11 September 2024
- Published by Academician Publishing
Erişkin Konjenital Kalp Hastalıklarına Perkütan Girişimsel Yaklaşımlar
İnsan bilişsel, duyuşsal ve fiziksel olarak doğaya karşı yüksek bir adaptasyon yetisi ile dünyaya gelir. Bu yeti bireysel farklılıklar gösterse de tüm insanlarda zamanla belirginleşerek farklı şekillerde öğrenme ve yapabilme yeteneği olarak kendini gösterir. Fakat genetik ve yaşamsal faktörlerin etkisiyle bazı insanların farklı alanlarda öğrenme ve yapabilme potansiyelleri akranlarına göre çok daha yüksektir. Yetenekli sıfatı da bu yüksek potansiyelli insanları tamınlamak için kullanılır.